블로그
- #[social affairs] New virus cases bounce back to over 40 on surge in domestic infections The number of new daily coronavirus cases in South Korea bounced back to above 40 on Thursday as domestic It marked the first time since July 29 that the daily rise in COVID-19 cases reached above 40.
- 글로벌녹색성장연구소, 주한뉴질랜드대사관 온라인 세미나 공동 개최 How can we tackle climate change under COVID-19? Speakers from New Zealand, the Pacific and Korea shared their views on promoting international collaboration
- #20 Being a foreign student during COVID-19 pandemic The COVID-19 was an unexpected twist that has profoundly changed how we live in South Korea. friends were worried about me because at that time the situation here was bad and they told me not go to Korea
- South Korea Tops in Sustainable Development Report 2020:지속가능발전보고서2020에서 한국 1위 Development Report 2020 - Sustainable Development Report Learning the lessons: Among OECD countries, South Korea was best able to address the health impacts of Covid-19 while mitigating impacts on the economy The
- 제넥신, 코로나19 DNA백신 인도네시아 특허관련 회사라고함 - 아래는 다음달 인도네시아에서 임상을 시작한다던 기사관련 포스팅 - 아래는 관련 기사 영문 번역 Kalbe Farma will not get a patent for COVID collaboration with Genexine, a pharmaceutical company from South Korea.
- 코로나19에 의한 소비자 구매 영향 온라인 uv 변화량은 활용하기 어려워 해당 레포트가 참고가 많이 됐음 https://www.gfk.com/kr/insights/report/gfk-covid-19/ https://www.gfk.com /kr/insights/report/gfk-covid-19/ GfK Korea - 코로나 19 의 가전시장 영향 분석 리포트 코로나 확진자 수 추이가 급상승하는 2/17주차 부터 온라인
- 파이낸셜타임스 엇그제 4월 6일자 기사 - 씨젠 매출 1조 원 예상.. molecular diagnostics company in Seoul, has cut back production of kits for 60 other diseases to focus on Covid (중략) South Korea has rapidly become one of the world’s biggest producers of test kits for coro.......
← 이전
3 페이지